Replies to post #136751 on PharmaCyte Biotech Inc (PMCB)

[DragonBear]

12 months to two years in my opinion

If Kenny falls back to Phase 1.

You can't time travel back, and restructure the Lohr studies of 1999, to generate data acceptable to the FDA. As long as Kenny pursues the Phase 2b nonsense, the Lohr studies remain an issue.

Pmcb does nothing quickly. Why would they?

More years of salary for the 3 amigos.